In the immunologically “cold” MOC2-huEGFR model (39), we found that anti–PD-L1 monotherapy does not elicit an anti-tumor response (Figure 4C), despite gradually increased endogenous Pd-l1 expression on growing tumor. The gene discussed is CD274; the disease is neoplasm.